<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>KLARON- sulfacetamide sodium lotion </strong><br>Valeant Pharmaceuticals North America LLC<br></p></div>
<h1><span class="Bold">KLARON<span class="Sup">®</span> (sodium sulfacetamide lotion) Lotion, 10%</span></h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="ID_92d18087-cedd-4116-998e-a6c11ff34146"></a><a name="section-1"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">Each mL of <span class="Bold">Klaron<span class="Sup">®</span></span> (sodium sulfacetamide lotion) <span class="Bold">Lotion, 10%</span> contains 100 mg of sodium sulfacetamide in a vehicle consisting of purified water; propylene glycol; lauramide DEA (and) diethanolamine; polyethylene glycol 400, monolaurate; hydroxyethyl cellulose; sodium chloride; sodium metabisulfite; methylparaben; xanthan gum; EDTA and simethicone.</p>
<p>Sodium sulfacetamide is a sulfonamide with antibacterial activity. Chemically, sodium sulfacetamide is N'-[(4-aminophenyl)sulfonyl]-acetamide, monosodium salt, monohydrate. The structural formula is:</p>
<div class="Figure">
<a name="id224"></a><img alt="Chemical Structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=66ab38ea-5cea-47be-97f2-486517999fb0&amp;name=klaron-01.jpg">
</div>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="ID_3fe9e562-04ec-4a09-93f1-2cfdea7859df"></a><a name="section-2"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">The most widely accepted mechanism of action of sulfonamides is the Woods-Fildes theory, based on sulfonamides acting as a competitive inhibitor of para-aminobenzoic acid (PABA) utilization, an essential component for bacterial growth. While absorption through intact skin in humans has not been determined, <span class="Italics">in vitro</span> studies with human cadaver skin indicated a percutaneous absorption of about 4%. Sodium sulfacetamide is readily absorbed from the gastrointestinal tract when taken orally and excreted in the urine largely unchanged. The biological half-life has been reported to be between 7 to 13 hours.</p>
<div class="Section" data-sectionCode="43682-4">
<a name="ID_a3cc4b1a-7d6a-4093-9ae5-bac6d564686c"></a><a name="section-2.1"></a><p></p>
<p class="First">The pharmacokinetics of sulfacetamide and its major metabolite sulfaniliamide in <span class="Bold">Klaron Lotion</span> was evaluated in adult subjects (N=14) with <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne vulgaris</span>. The subjects applied <span class="Bold">Klaron Lotion</span> to their face, back, chest and shoulders every 12 hours for 28 days. The percentage of the applied dose of <span class="Bold">Klaron Lotion</span> excreted in the urine as sulfacetamide plus sulfanilamide, ranged from 0.08 to 0.33%.</p>
</div>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="ID_62b34db7-36a9-4351-841c-de8b0a51801d"></a><a name="section-3"></a><p></p>
<h1>INDICATIONS</h1>
<p class="First"><span class="Bold">Klaron Lotion</span> is indicated in the topical treatment of <span class="Italics"><span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne vulgaris</span></span>.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="contraindications"></a><a name="section-4"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First"><span class="Bold">Klaron Lotion</span> is contraindicated for use by patients having known <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to sulfonamides or any other component of this preparation (see <span class="Bold"><a href="#warnings">WARNINGS</a></span> section).</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="warnings"></a><a name="section-5"></a><p></p>
<h1>WARNINGS</h1>
<p class="First">Fatalities have occurred, although rarely, due to severe reactions to sulfonamides including <span class="product-label-link" type="condition" conceptid="141651" conceptname="Stevens-Johnson syndrome">Stevens-Johnson syndrome</span>, <span class="product-label-link" type="condition" conceptid="443754" conceptname="Lyell's toxic epidermal necrolysis, subepidermal type">toxic epidermal necrolysis</span>, fulminant <span class="product-label-link" type="condition" conceptid="4337543" conceptname="Hepatic necrosis">hepatic necrosis</span>, <span class="product-label-link" type="condition" conceptid="440689" conceptname="Agranulocytosis">agranulocytosis</span>, <span class="product-label-link" type="condition" conceptid="137829" conceptname="Aplastic anemia">aplastic anemia</span>, and other <span class="product-label-link" type="condition" conceptid="40528016" conceptname="Disorder of hematopoietic system">blood dyscrasias</span>. <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Hypersensitivity reactions</span> may occur when a sulfonamide is readministered, irrespective of the route of administration. Sensitivity reactions have been reported in individuals with no prior history of sulfonamide <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span>. At the first sign of <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span>, <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">skin rash</span> or other reactions, discontinue use of this preparation (see <span class="Bold"><a href="#adverse_reactions">ADVERSE REACTIONS</a></span> section).</p>
<p><span class="Bold">Klaron Lotion</span> contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe <span class="product-label-link" type="condition" conceptid="317009" conceptname="Asthma">asthmatic</span> episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in <span class="product-label-link" type="condition" conceptid="317009" conceptname="Asthma">asthmatic</span> than in non-<span class="product-label-link" type="condition" conceptid="317009" conceptname="Asthma">asthmatic</span> people (see <span class="Bold"><a href="#contraindications">CONTRAINDICATIONS</a></span> section).</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="ID_b8fa9d79-f425-442a-933f-2a1f7aca161d"></a><a name="section-6"></a><p></p>
<h1>PRECAUTIONS</h1>
<div class="Section" data-sectionCode="34072-9">
<a name="ID_29408444-3e13-4b3d-8b33-d55076c8f719"></a><a name="section-6.1"></a><p></p>
<h2>General</h2>
<p class="First">For external use only. Keep away from eyes. If irritation develops, use of the product should be discontinued and appropriate therapy instituted. Patients should be carefully observed for possible local irritation or sensitization during long-term therapy. <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Hypersensitivity reactions</span> may occur when a sulfonamide is readministered irrespective of the route of administration, and cross-sensitivity between different sulfonamides may occur. Sodium sulfacetamide can cause reddening and scaling of the skin. Particular caution should be employed if areas of involved skin to be treated are denuded or abraded.</p>
<p><span class="Bold">Keep out of the reach of children.</span></p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="ID_dec14c5a-f2ce-4f55-9284-ec713d371ce8"></a><a name="section-6.2"></a><p></p>
<h2>Carcinogenesis, Mutagenesis and Impairment of Fertility</h2>
<p class="First">Long-term studies in animals have not been performed to evaluate carcinogenic potential.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="ID_9b2980e0-f7c8-434f-89ae-11dc744bb29c"></a><a name="section-6.3"></a><p></p>
<h2>Pregnancy – Category C</h2>
<p class="First">Animal reproduction studies have not been conducted with <span class="Bold">Klaron<span class="Sup">®</span> Lotion</span>. It is also not known whether <span class="Bold">Klaron Lotion</span> can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. <span class="Bold">Klaron Lotion</span> should be given to a pregnant woman only if clearly needed.</p>
<p><span class="product-label-link" type="condition" conceptid="4326231" conceptname="Kernicterus">Kernicterus</span> may occur in the newborn as a result of treatment of a pregnant woman at term with orally administered sulfonamide. There are no adequate and well controlled studies of <span class="Bold">Klaron Lotion</span> in pregnant women, and it is not known whether topically applied sulfonamides can cause fetal harm when administered to a pregnant woman.</p>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="ID_b9cf23a1-ff50-483e-84f3-f2e238874bd9"></a><a name="section-6.4"></a><p></p>
<h2>Nursing Mothers</h2>
<p class="First">It is not known whether sodium sulfacetamide is excreted in the human milk following topical use of <span class="Bold">Klaron Lotion</span>. Systemically administered sulfonamides are capable of producing <span class="product-label-link" type="condition" conceptid="4326231" conceptname="Kernicterus">kernicterus</span> in the infants of lactating women. Small amounts of orally administered sulfonamides have been reported to be eliminated in human milk. Because many drugs are excreted in human milk, caution should be exercised in prescribing for nursing women.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="ID_d93c7038-9714-4057-9218-1eeccb11afd3"></a><a name="section-6.5"></a><p></p>
<h2>Pediatric Use</h2>
<p class="First">Safety and effectiveness in pediatric patients under the age of 12 have not been established.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="adverse_reactions"></a><a name="section-7"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First">In controlled clinical trials for the management of <span class="Italics"><span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne vulgaris</span></span>, the occurrence of adverse reactions associated with the use of <span class="Bold">Klaron Lotion</span> was infrequent and restricted to local events. The total incidence of adverse reactions reported in these studies was less than 2%. Only one of 105 patients treated with <span class="Bold">Klaron Lotion</span> had adverse reactions of <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">erythema</span>, <span class="product-label-link" type="condition" conceptid="4302654" conceptname="Itching">itching</span> and <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span>. It has been reported that sodium sulfacetamide may cause local irritation, <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">stinging</span> and burning. While the irritation may be transient, occasionally, the use of medication has to be discontinued.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="ID_729a11bc-91c7-4685-b0f2-57b10b9b5ae8"></a><a name="section-8"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">Apply a thin film to affected areas twice daily.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="ID_27e34b85-cb50-4318-b4b0-10bef868bd5c"></a><a name="section-9"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">4 FL OZ (118 mL) bottles (NDC 0187-5198-04).</p>
<p>Store at Controlled Room Temperature 20 to 25°C (68 to 77°F) [see USP].<br>Shake well before using. Keep tightly closed.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_7c845400-43b0-493c-a29c-4e01b3e866dc"></a><a name="section-10"></a><p></p>
<p class="First">Prescribing information as of July 2012.</p>
<p>Distributed by:<br>Valeant Pharmaceuticals North America LLC<br>Bridgewater, NJ 08807</p>
<p>©2012 Valeant Pharmaceuticals North America LLC</p>
<p>50074012D<br>Origin Canada<br>Rev. 07/12</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="ID_3efdbd61-d1ef-492a-9eae-e9875b3350ef"></a><a name="section-11"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL - 118 mL Bottle Carton</h1>
<p class="First">NDC 0187-5198-04</p>
<p><span class="Italics"><span class="Bold">Klar</span>on</span><span class="Sup">®</span></p>
<p><span class="Italics">sodium </span><br><span class="Italics">sulfacetamide lotion</span></p>
<p><span class="Bold">Lotion, 10%</span></p>
<p>FOR TOPICAL USE ONLY</p>
<p><span class="Bold">One</span> 4 fl oz (118 mL) Bottle</p>
<p>VALEANT<br>Pharmaceuticals North America LLC</p>
<div class="Figure">
<a name="id422"></a><img alt="PRINCIPAL DISPLAY PANEL - 118 mL Bottle Carton" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=66ab38ea-5cea-47be-97f2-486517999fb0&amp;name=klaron-02.jpg">
</div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>KLARON 		
					</strong><br><span class="contentTableReg">sulfacetamide sodium lotion</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0187-5198</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">TOPICAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>sulfacetamide sodium</strong> (sulfacetamide) </td>
<td class="formItem">sulfacetamide sodium</td>
<td class="formItem">10 mg  in 1 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>water</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>propylene glycol</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Lauric Diethanolamide</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>diethanolamine</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>polyethylene glycol 400</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>sodium chloride</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>sodium metabisulfite</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>methylparaben</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>xanthan gum</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>EDETIC ACID</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0187-5198-04</td>
<td class="formItem">118 mL in 1 BOTTLE, PLASTIC</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA</td>
<td class="formItem">NDA019931</td>
<td class="formItem">12/23/1996</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Valeant Pharmaceuticals North America LLC
							(042230623)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Valeant Pharmaceuticals International, Inc</td>
<td class="formItem"></td>
<td class="formItem">245141858</td>
<td class="formItem">MANUFACTURE(0187-5198)</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 4/2014<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>0c16b9dc-9474-4884-a2ac-45cac65e95d6</div>
<div>Set id: 66ab38ea-5cea-47be-97f2-486517999fb0</div>
<div>Version: 3</div>
<div>Effective Time: 20140430</div>
</div>
</div> <div class="DistributorName">Valeant Pharmaceuticals North America LLC</div></p>
</body></html>
